These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 26462506)
21. [Human papilloma virus infection and cervical cancer: a public health perspective]. Torres-Poveda KJ; Burguete A; Bermúdez-Morales VH; Madrid-Marina V Rev Invest Clin; 2008; 60(5):414-20. PubMed ID: 19227439 [No Abstract] [Full Text] [Related]
22. [Can human papillomavirus testing and vaccination prevent cervical cancer?]. Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778 [TBL] [Abstract][Full Text] [Related]
23. The latest recommendations from the USPSTF. Campos-Outcalt D J Fam Pract; 2012 May; 61(5):278-82. PubMed ID: 22577630 [TBL] [Abstract][Full Text] [Related]
24. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Davies P; Arbyn M; Dillner J; Kitchener HC; Meijer CJ; Ronco G; Hakama M Int J Cancer; 2006 Feb; 118(4):791-6. PubMed ID: 16287075 [TBL] [Abstract][Full Text] [Related]
25. The prevention of cervical cancer in Africa. Fiander AN Womens Health (Lond); 2011 Jan; 7(1):121-32. PubMed ID: 21175396 [TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries. Luciani S; Jauregui B; Kieny C; Andrus JK Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024 [TBL] [Abstract][Full Text] [Related]
28. Harnessing the power of prevention: human papillomavirus vaccines. Mayeaux EJ Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680 [TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus infection. Recent findings on progression to cervical cancer. Adimora AA; Quinlivan EB Postgrad Med; 1995 Sep; 98(3):109-12, 115-6, 120. PubMed ID: 7675735 [TBL] [Abstract][Full Text] [Related]
30. [Excessive spending by misuse of clinical laboratory]. Benítez-Arvizu G; Novelo-Garza B; Mendoza-Valdez AL; Galván-Cervantes J; Morales-Rojas A Rev Med Inst Mex Seguro Soc; 2016; 54 Suppl 2():S216-23. PubMed ID: 27561028 [TBL] [Abstract][Full Text] [Related]
31. [Human papillomavirus and cervical cancer in México: a constant struggle]. Torres-Poveda K; Madrid-Marina V Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S118-20. PubMed ID: 26462506 [TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus vaccines and prevention of cervical cancer. Jansen KU; Shaw AR Annu Rev Med; 2004; 55():319-31. PubMed ID: 14746524 [TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus and cervical disease in adolescents. Guido R Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460 [TBL] [Abstract][Full Text] [Related]
34. Reducing patient risk for human papillomavirus infection and cervical cancer. Herbert J; Coffin J J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060 [TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]